Role of vascular risk factors and vascular dysfunction in Alzheimer's disease
- PMID: 20101718
- PMCID: PMC2918901
- DOI: 10.1002/msj.20155
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease
Abstract
Recent findings indicate that vascular risk factors and neurovascular dysfunction play integral roles in the pathogenesis of Alzheimer's disease. In addition to aging, the most common risk factors for Alzheimer's disease are apolipoprotein e4 allele, hypertension, hypotension, diabetes, and hypercholesterolemia. All of these can be characterized by vascular pathology attributed to conditions such as cerebral amyloid angiopathy and subsequent blood-brain barrier dysfunction. Many epidemiological, clinical, and pharmacotherapeutic studies have assessed the associations between such risk factors and Alzheimer's disease and have found positive associations between hypertension, hypotension, and diabetes mellitus. However, there are still many conflicting results from these population-based studies, and they should be interpreted carefully. Recognition of these factors and the mechanisms by which they contribute to Alzheimer's disease will be beneficial in the current treatment regimens for Alzheimer's disease and in the development of future therapies. Here we discuss vascular factors with respect to Alzheimer's disease and dementia and review the factors that give rise to vascular dysfunction and contribute to Alzheimer's disease.
(c) 2010 Mount Sinai School of Medicine.
Similar articles
-
Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study.Brain. 2023 Jan 5;146(1):337-348. doi: 10.1093/brain/awac354. Brain. 2023. PMID: 36374264 Free PMC article.
-
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.Acta Neuropathol. 2009 Jul;118(1):103-13. doi: 10.1007/s00401-009-0522-3. Epub 2009 Mar 25. Acta Neuropathol. 2009. PMID: 19319544 Free PMC article. Review.
-
Relation between vascular risk factors and neuropsychological test performance among elderly persons with Alzheimer's disease.J Neurol Sci. 2007 Jun 15;257(1-2):194-201. doi: 10.1016/j.jns.2007.01.030. Epub 2007 Feb 27. J Neurol Sci. 2007. PMID: 17328914 Free PMC article.
-
Analysis of genetics and risk factors of Alzheimer's Disease.Neuroscience. 2016 Jun 14;325:124-31. doi: 10.1016/j.neuroscience.2016.03.051. Epub 2016 Mar 26. Neuroscience. 2016. PMID: 27026590
-
Vascular and metabolic dysfunction in Alzheimer's disease: a review.Exp Biol Med (Maywood). 2011 Jul;236(7):772-82. doi: 10.1258/ebm.2011.010355. Epub 2011 Jun 16. Exp Biol Med (Maywood). 2011. PMID: 21680755 Review.
Cited by
-
Cerebral blood flow in Alzheimer's disease.Vasc Health Risk Manag. 2012;8:599-611. doi: 10.2147/VHRM.S34874. Epub 2012 Oct 23. Vasc Health Risk Manag. 2012. PMID: 23109807 Free PMC article.
-
Smoking and Alzheimer's disease among Mongolian and Han Chinese aged 55 years and over living in the Inner Mongolia farming area of China.Neural Regen Res. 2012 Jul 15;7(20):1570-7. doi: 10.3969/j.issn.1673-5374.2012.20.007. Neural Regen Res. 2012. PMID: 25657695 Free PMC article.
-
Polymorphism in apoA1 Influences High-Density Lipoprotein Cholesterol Levels but Is Not a Major Risk Factor of Alzheimer's Disease.Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):249-57. doi: 10.1159/000329910. Epub 2012 Jan 17. Dement Geriatr Cogn Dis Extra. 2011. PMID: 22323901 Free PMC article.
-
Function and comorbidities of apolipoprotein e in Alzheimer's disease.Int J Alzheimers Dis. 2011 Apr 5;2011:974361. doi: 10.4061/2011/974361. Int J Alzheimers Dis. 2011. PMID: 21559182 Free PMC article.
-
Regional association of pCASL-MRI with FDG-PET and PiB-PET in people at risk for autosomal dominant Alzheimer's disease.Neuroimage Clin. 2017 Dec 6;17:751-760. doi: 10.1016/j.nicl.2017.12.003. eCollection 2018. Neuroimage Clin. 2017. PMID: 29527482 Free PMC article.
References
-
- Takeda S, Sato N, Ogihara T, Morishita R. The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential. Front Biosci. 2008;13:2253–2265. - PubMed
-
- Whitehouse PJ, Sciulli CG, Mason RM. Dementia drug development: use of information systems to harmonize global drug development. Psychopharmacol Bull. 1997;33:129–133. - PubMed
-
- Hardy J. A hundred years of Alzheimer's disease research. Neuron. 2006;52:3–13. - PubMed
-
- Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology. 2001;56:1683–1689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical